发文分析
近年国家/地区发文量统计
| 国家/地区 | 数量 |
|---|---|
| USA | 487 |
| England | 302 |
| GERMANY (FED REP GER) | 159 |
| Denmark | 147 |
| Canada | 137 |
| Italy | 137 |
| CHINA MAINLAND | 109 |
| Netherlands | 90 |
| Sweden | 90 |
| Australia | 88 |
近年机构发文量统计
| 机构 | 数量 |
|---|---|
| ASTRAZENECA | 82 |
| SANOFI-AVENTIS | 78 |
| NOVO NORDISK | 75 |
| UNIVERSITY OF TORONTO | 72 |
| HARVARD UNIVERSITY | 65 |
| UNIVERSITY OF COPENHAGEN | 65 |
| UNIVERSITY OF NOTTINGHAM | 57 |
| UNIVERSITY OF GRONINGEN | 48 |
| UNIVERSITY OF LEICESTER | 45 |
| UNIVERSITY OF LONDON | 45 |
近年文章引用他刊数据
| 文章名称 | 引用次数 |
|---|---|
| Incretin hormones: Their role in health and disease | 70 |
| Why do SGLT2 inhibitors reduce heart failure hospitaliza... | 65 |
| Evaluation of the effects of dapagliflozin, a sodium-glu... | 42 |
| Identification of barriers to insulin therapy and approa... | 38 |
| GLP-1 receptor agonists for prevention of cardiorenal ou... | 35 |
| Effect of SGLT2 inhibitors on cardiovascular, renal and ... | 35 |
| Effects of sodium-glucose co-transporter 2 (SGLT2) inhib... | 35 |
| Therapeutic inertia in the treatment of hyperglycaemia i... | 35 |
| Ertugliflozin plus sitagliptin versus either individual ... | 33 |
| Luseogliflozin improves liver fat deposition compared to... | 33 |
近年被他刊引用数据
| 期刊名称 | 引用次数 |
|---|---|
| DIABETES OBES METAB | 868 |
| DIABETES THER | 449 |
| DIABETES RES CLIN PR | 211 |
| INT J MOL SCI | 168 |
| FRONT ENDOCRINOL | 147 |
| CARDIOVASC DIABETOL | 144 |
| DIABETES CARE | 139 |
| SCI REP-UK | 135 |
| NUTRIENTS | 132 |
| J DIABETES INVEST | 117 |